Clinical Relevance of <i>HER2</i> Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
Giuseppe Curigliano(European Institute of Oncology), Aron Goldhirsch(European Institute of Oncology)
Cited by 257
Related Papers
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
|Annals of Oncology|2012|854
Antibody–drug conjugates in solid tumors: a look into novel targets
|Journal of Hematology & Oncology|2021|251